Hudson Bay Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-614,744
Closed -$61M 568
2019
Q3
$61M Buy
614,744
+181,248
+42% +$17.2M 1.68% 9
2019
Q2
$40.1M Buy
433,496
+15,800
+4% +$1.5M 0.92% 20
2019
Q1
$39.4M Buy
+417,696
New +$36.5M 0.51% 35
2018
Q3
Sell
-30,000
Closed -$2.38M 987
2018
Q2
$2.38M Hold
30,000
0.03% 464
2018
Q1
$2.68M Buy
+30,000
New +$2.88M 0.06% 383
2017
Q2
Sell
-63,520
Closed -$7.9M 930
2017
Q1
$7.9M Buy
63,520
+54,920
+639% +$6.57M 0.11% 194
2016
Q4
$995K Buy
+8,600
New +$958K 0.02% 472

Other funds holding CELG

Hudson Bay Capital Management's CELG Position: Q4 2019 in Review

Hudson Bay Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 614,744 shares — an estimated $61M sold.

Hudson Bay Capital Management first reported a position in CELG in Q4 2016 and held it in 7 quarters. The position peaked at $61M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hudson Bay Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hudson Bay Capital Management sold 614,744 Celgene Corp shares in Q4 2019, an estimated $61M.
  • Hudson Bay Capital Management first reported a position in Celgene Corp in Q4 2016 and held it in 7 quarters.
  • Hudson Bay Capital Management's Celgene Corp position peaked at $61M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hudson Bay Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.